Hematologic Malignancies Market Share To Reach USD 120.56 Billion By 2028, Trends – Increasing focus on development of new Therapeutics.
Rising global prevalence of blood cancer, growing awareness about benefits of early diagnosis, and development of strong pipeline therapeutics are key factors driving market revenue growth Market Size – USD 53.46 Billion in 2020, Market Growth – at a CAGR of 10.7%, Market Trends – Increasing focus on development of new therapeutics The Global Hematologic Malignancies Market size is expected to reach USD 120.56 Billion by 2028 at a CAGR of 10.7%, according to the latest report by Reports and Data. Rising prevalence of blood cancer, presence of strong pipeline therapeutics, and increasing expenditure in healthcare sector are key factors expected to drive market revenue growth over the forecast period. In addition, rapidly increasing geriatric population, rising awareness about early diagnosis and treatment, growing focus on developing advanced therapeutics, and increasing product approvals are expected to support market growth going ahead. Hematologic malignancies are cancers tha